BriaCell Therapeutics Corp. (BCTX)
NASDAQ: BCTX · Real-Time Price · USD
3.470
-0.230 (-6.22%)
At close: Apr 1, 2025, 4:00 PM
3.480
+0.010 (0.29%)
After-hours: Apr 1, 2025, 4:45 PM EDT

BriaCell Therapeutics Income Statement

Millions USD. Fiscal year is Aug - Jul.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Jan '25 Jul '24 Jul '23 Jul '22 Jul '21 Jul '20 2019 - 2015
Selling, General & Admin
6.446.658.517.584.961.54
Upgrade
Research & Development
20.8826.6814.767.712.022.4
Upgrade
Operating Expenses
27.3233.3323.2715.296.983.94
Upgrade
Operating Income
-27.32-33.33-23.27-15.29-6.98-3.94
Upgrade
Interest Expense
----0-0.08-0.03
Upgrade
Interest & Investment Income
0.080.290.890.140-
Upgrade
Earnings From Equity Investments
-0.2-0.11----
Upgrade
Currency Exchange Gain (Loss)
0-0.03-0.04-0.03-2.18-0.01
Upgrade
Other Non Operating Income (Expenses)
15.7228.242.12-11.65-4.450.02
Upgrade
EBT Excluding Unusual Items
-11.72-4.93-20.3-26.84-13.67-3.96
Upgrade
Other Unusual Items
-----0.14-0.06
Upgrade
Pretax Income
-11.72-4.93-20.3-26.84-13.82-4.02
Upgrade
Earnings From Continuing Operations
-11.72-4.93-20.3-26.84-13.82-4.02
Upgrade
Minority Interest in Earnings
0.130.14----
Upgrade
Net Income
-11.59-4.79-20.3-26.84-13.82-4.02
Upgrade
Net Income to Common
-11.59-4.79-20.3-26.84-13.82-4.02
Upgrade
Shares Outstanding (Basic)
211100
Upgrade
Shares Outstanding (Diluted)
211100
Upgrade
Shares Change (YoY)
58.67%5.35%0.81%242.82%533.09%23.16%
Upgrade
EPS (Basic)
-6.91-4.37-19.50-25.98-45.85-84.56
Upgrade
EPS (Diluted)
-6.92-4.37-19.50-25.98-45.85-84.56
Upgrade
Free Cash Flow
-22.45-24.58-23.74-12.48-7.75-1.27
Upgrade
Free Cash Flow Per Share
-13.39-22.41-22.80-12.09-25.72-26.60
Upgrade
EBITDA
-27.19-33.25-23.26-15.27-6.96-3.92
Upgrade
D&A For EBITDA
0.130.080.020.020.020.02
Upgrade
EBIT
-27.32-33.33-23.27-15.29-6.98-3.94
Upgrade
Updated Mar 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q